Solution structure and dynamics of G1TE, a nonphosphorylated cyclic peptide inhibitor for the Grb2 SH2 domain

被引:16
|
作者
Lou, YC
Lung, FDT
Pai, MT
Tzeng, SR
Wei, SY
Roller, PP
Cheng, JW [1 ]
机构
[1] Natl Tsing Hua Univ, Dept Life Sci, Div Struct Biol & Biomed Sci, Hsinchu 300, Taiwan
[2] China Med Coll, Dept Nutr, Taichung 400, Taiwan
[3] NCI, Med Chem Lab, Div Basic Sci, NIH, Bethesda, MD 20892 USA
关键词
nuclear magnetic resonance; solution structure; signal transduction; drug design;
D O I
10.1006/abbi.1999.1513
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The solution structure and dynamics of G1TE, a nonphosphorylated cyclic peptide inhibitor for the Grb2 SH2 domain, was determined using two-dimensional NMR and simulated annealing methods. G1TE consists of 10 amino acids and a C-terminal Cys cyclized through its side-chain sulfur atom by a thioether linkage to its N terminus. The results indicate that G1TE assumes a circle-like shape in solution in which all the side chains are protruding outside, and none of the residues are involved in intramolecular hydrogen bonding. The average root-mean-square deviations were found to be 0.41 +/- 0.11 Angstrom for the backbone heavy atoms C, C alpha, and N, and 1.03 +/- 0.14 Angstrom for all heavy atoms in a family of 10 structures. N-15 relaxation measurements indicate that G1TE has rather restricted dynamics in the fast time scale within its backbone. However, residues Tyr3, Val6, and Gly7 may be involved in a possible conformational exchange. The structural comparison between G1TE in solution and the BCR-Abl phosphopeptide bound to Grb2 SH2 domain revealed that G1TE may form a larger circle-like binding surface than the BCR-Abl phosphopeptide in the bound form. Also, the restricted backbone dynamics of G1TE may result in a reduced loss of entropy and can compensate for the absence of a phosphate group at the Tyr3 position. These structural and dynamic properties of G1TE may provide a molecular basis for understanding its interactions with the Grb2 SH2 domain. (C) 1999 Academic Press.
引用
收藏
页码:309 / 314
页数:6
相关论文
共 50 条
  • [21] INDEPENDENT BINDING OF PEPTIDE LIGANDS TO THE SH2 AND SH3 DOMAINS OF GRB2
    LEMMON, MA
    LADBURY, JE
    MANDIYAN, V
    ZHOU, M
    SCHLESSINGER, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (50) : 31653 - 31658
  • [22] Role of water molecules for binding inhibitors in the SH2 domain of Grb2: A molecular dynamics study
    Leroux, Vincent
    Gresh, Nohad
    Liu, Wang-Qing
    Garbay, Christiane
    Maigret, Bernard
    JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 2007, 806 (1-3): : 51 - 66
  • [23] Chemical shift assignments and secondary structure of the Grb2 SH2 domain by heteronuclear NMR spectroscopy
    Wang, YS
    Frederick, AF
    Senior, MM
    Lyons, BA
    Black, S
    Kirschmeier, P
    Perkins, LM
    Wilson, O
    JOURNAL OF BIOMOLECULAR NMR, 1996, 7 (02) : 89 - 98
  • [24] Conformation of an Shc-derived phosphotyrosine-containing peptide complexed with the Grb2 SH2 domain
    Kenji Ogura
    Shigeo Tsuchiya
    Hiroaki Terasawa
    Satoru Yuzawa
    Hideki Hatanaka
    Valsan Mandiyan
    Joseph Schlessinger
    Fuyuhiko Inagaki
    Journal of Biomolecular NMR, 1997, 10 : 273 - 278
  • [25] Structure-activity relationships of small phosphopeptides, inhibitors of Grb2 SH2 domain, and their prodrugs
    Liu, WQ
    Vidal, M
    Olszowy, C
    Million, E
    Lenoir, C
    Dhôtel, H
    Garbay, C
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (05) : 1223 - 1233
  • [26] Crystal structures of a high-affinity macrocyclic peptide mimetic in complex with the Grb2 SH2 domain
    Phan, J
    Shi, ZD
    Burke, TR
    Waugh, DS
    JOURNAL OF MOLECULAR BIOLOGY, 2005, 353 (01) : 104 - 115
  • [27] Utilization of a nitrobenzoxadiazole (NBD) fluorophore in the design of a Grb2 SH2 domain-binding peptide mimetic
    Shi, ZD
    Karki, RG
    Oishi, S
    Worthy, KM
    Bindu, LK
    Dharmawardana, PG
    Nicklaus, MC
    Bottaro, DP
    Fisher, RJ
    Burke, TR
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (05) : 1385 - 1388
  • [28] Preliminary crystallographic characterization of the Grb2 SH2 domain in complex with a FAK-derived phosphotyrosyl peptide
    Chen, Hsiao-Hsin
    Chen, Cuei-Wen
    Chang, Yu-Yung
    Shen, Tang-Long
    Hsu, Chun-Hua
    ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2010, 66 : 195 - 197
  • [29] Crystal structures of the SH2 domain of Grb2: Highlight on the binding of a new high-affinity inhibitor
    Nioche, P
    Liu, WQ
    Broutin, I
    Charbonnier, F
    Latreille, MT
    Vidal, M
    Roques, B
    Garbay, C
    Ducruix, A
    JOURNAL OF MOLECULAR BIOLOGY, 2002, 315 (05) : 1167 - 1177
  • [30] Conformation of an Shc-derived phosphotyrosine-containing peptide complexed with the Grb2 SH2 domain
    Ogura, K
    Tsuchiya, S
    Terasawa, H
    Yuzawa, S
    Hatanaka, H
    Mandiyan, V
    Schlessinger, J
    Inagaki, F
    JOURNAL OF BIOMOLECULAR NMR, 1997, 10 (03) : 273 - 278